Merck Remains Active In Pursuit Of Mevacor Rx-to-OTC Switch In U.S.
This article was originally published in The Tan Sheet
Executive Summary
Merck continues to work with FDA over a possible switch of Mevacor (lovastatin) to over-the-counter status in the U.S. this year